Profile data is unavailable for this security.
About the company
Xbrane Biopharma AB, formerly Xbrane Bioscience AB, is a Sweden-based provider of biotechnology research and development services. It develops biogenerics for injectable slow release drugs and high-yield protein expression technology for the development of biosimilars. The Company's main products are Sperotide, a generic on the originator drug marketed under the trademarks Decapeptyl, Trelstar and Pamorelin, as well as Xlucane, a biosimilar on the originator drug sold under the trademark Lucentis.
- Revenue in SEK (TTM)152.35m
- Net income in SEK-46.17m
- Incorporated2008
- Employees29.00
- LocationXbrane Biopharma ABRetzius Vag 8SOLNA 171 65SwedenSWE
- Phone+46 855905600
- Websitehttps://xbrane.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Opsy Holding AB | 6.69m | -7.86m | 81.26m | 7.00 | -- | 52.66 | -- | 12.14 | -8.55 | -8.55 | 0.705 | 0.1215 | 0.8126 | -- | 9.41 | 955,857.10 | -95.38 | -129.63 | -199.92 | -161.05 | 144.70 | -- | -117.38 | -2,431.63 | -- | -69.76 | 0.435 | -- | -- | -- | 62.94 | -- | 43.17 | -- |
| Biosergen AB | 0.00 | -40.82m | 90.17m | 1.00 | -- | -- | -- | -- | -17.68 | -17.68 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -112.64 | -- | -- | -- |
| Biovica International AB | 9.86m | -76.47m | 99.90m | 24.00 | -- | 0.8488 | -- | 10.13 | -0.6375 | -0.6375 | 0.0684 | 0.4241 | 0.0799 | 12.71 | 4.46 | 365,333.30 | -61.92 | -58.22 | -70.41 | -66.49 | -171.53 | -462.09 | -775.22 | -1,804.16 | 8.11 | -- | 0.0239 | -- | 18.23 | 38.83 | 29.80 | -- | -47.26 | -- |
| Coegin Pharma AB | 79.00k | -20.50m | 102.00m | 3.00 | -- | 21.50 | -- | 1,291.11 | -0.824 | -0.824 | 0.0032 | 0.1907 | 0.0039 | -- | 2.16 | -- | -101.52 | -113.82 | -136.64 | -160.62 | -974.68 | -- | -25,945.57 | -170,432.90 | -- | -681.70 | -- | -- | -- | -- | 13.81 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -68.54m | 102.09m | 12.00 | -- | 1.59 | -- | -- | -1.40 | -1.40 | 0.00 | 1.07 | 0.00 | -- | -- | 0.00 | -108.82 | -43.50 | -168.39 | -50.76 | -- | -- | -- | -- | -- | -20.18 | 0.0052 | -- | -- | -- | -8.27 | -- | 1.47 | -- |
| Alzinova AB | 205.00k | -26.88m | 102.49m | 5.00 | -- | 0.501 | -- | 499.94 | -0.2846 | -0.2846 | 0.0022 | 1.23 | 0.0015 | -- | 0.3254 | 41,000.00 | -19.42 | -12.21 | -20.69 | -12.85 | -5,834.15 | -- | -13,114.15 | -21,390.81 | -- | -1,794.80 | 0.0062 | -- | -88.89 | -- | -24.71 | -- | 19.48 | -- |
| Alligator Bioscience AB | 514.00k | -51.35m | 102.73m | 13.00 | -- | 1.23 | -- | 199.87 | -1.09 | -1.09 | 0.0074 | 0.1566 | 0.0048 | -- | 1.98 | -- | -47.78 | -101.41 | -- | -222.85 | -- | -- | -9,990.27 | -526.56 | -- | -- | 0.8354 | -- | -99.11 | -34.77 | 78.05 | -- | 70.30 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -36.89m | 103.06m | 4.00 | -- | 4.13 | -- | -- | -5.98 | -5.98 | 0.00 | 3.53 | 0.00 | -- | -- | 0.00 | -150.00 | -137.53 | -190.93 | -169.50 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.58 | -- | -- | -- |
| Glycorex Transplantation AB (publ) | 38.84m | -7.72m | 106.20m | 20.00 | -- | 3.21 | 67.43 | 2.73 | -0.0983 | -0.0983 | 0.4952 | 0.438 | 0.7685 | 1.35 | 6.37 | 1,942,200.00 | -15.27 | -17.65 | -20.85 | -21.45 | 82.84 | 85.42 | -19.87 | -41.50 | 1.35 | -16.24 | 0.1682 | -- | 10.48 | 7.55 | 29.44 | -- | -37.57 | -- |
| Abera Bioscience AB | 0.00 | -10.45m | 112.71m | 5.00 | -- | 5.84 | -- | -- | -0.5692 | -0.5692 | 0.00 | 1.04 | 0.00 | -- | -- | -- | -49.58 | -63.36 | -74.82 | -81.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -850.27 | -- | -- | -- |
| Xbrane Biopharma AB | 152.35m | -46.17m | 127.86m | 29.00 | -- | 0.228 | -- | 0.8392 | -106.73 | 1,665.76 | 29.07 | 27.21 | 0.2013 | 0.2847 | 12.91 | 5,253,586.00 | -6.10 | -25.02 | -10.00 | -43.04 | 58.77 | -- | -30.30 | -144.31 | 3.43 | -1.80 | 0.0942 | -- | 2.87 | -- | 67.33 | -- | 105.02 | -- |
| SoftOx Solutions AS | 12.90m | -2.85m | 135.01m | 5.00 | -- | 1.31 | 176.60 | 10.47 | -0.001 | -0.001 | 0.0065 | 0.0445 | 0.123 | -- | 30.13 | 2,717,798.00 | -2.72 | -50.91 | -3.22 | -67.07 | -- | -- | -22.07 | -644.92 | 1.16 | -3.92 | 0.1212 | -- | 13.38 | 14.06 | -8.86 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -37.30m | 137.34m | 5.00 | -- | 2.47 | -- | -- | -0.0236 | -0.0236 | 0.00 | 0.0211 | 0.00 | -- | -- | 0.00 | -65.79 | -93.70 | -82.91 | -119.51 | -- | -- | -- | -- | -- | -- | 0.0018 | -- | -- | -- | 5.33 | -- | -- | -- |
| NextCell Pharma AB | 10.94m | -35.14m | 150.38m | 24.00 | -- | 2.27 | -- | 13.75 | -0.4414 | -0.4414 | 0.133 | 0.596 | 0.1384 | 51.23 | 4.68 | -- | -44.48 | -34.95 | -49.25 | -37.53 | -155.37 | -266.34 | -321.31 | -427.08 | 9.92 | -- | -- | -- | 2.56 | 25.13 | 16.25 | -- | 36.88 | -- |
| ViroGates A/S | 7.20m | -17.69m | 157.07m | 7.00 | -- | 32.33 | -- | 21.82 | -1.63 | -1.63 | 0.6609 | 0.3665 | 0.3568 | 0.9777 | 4.41 | 504,300.00 | -87.63 | -54.92 | -131.36 | -63.15 | 47.33 | 72.98 | -245.63 | -215.48 | 1.58 | -16.13 | 0.6277 | -- | -12.27 | 6.45 | -18.59 | -- | -- | -- |
| SenzaGen AB | 57.97m | -15.95m | 174.24m | 37.00 | -- | 2.03 | -- | 3.01 | -0.5405 | -0.5405 | 1.96 | 2.63 | 0.5084 | 7.26 | 3.57 | -- | -13.98 | -17.45 | -17.59 | -21.89 | 64.80 | 66.40 | -27.51 | -45.19 | 2.17 | -- | 0.1953 | -- | 0.4836 | 48.76 | -8.14 | -- | 169.98 | -- |
Data as of Mar 02 2026. Currency figures normalised to Xbrane Biopharma AB's reporting currency: Swedish Krona SEK
2.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Handelsbanken Fonder ABas of 31 Jan 2026 | 307.77k | 1.49% |
| SEB Funds ABas of 30 Jan 2026 | 93.88k | 0.46% |
| Storebrand Asset Management ASas of 31 Jan 2026 | 84.62k | 0.41% |
| FCG Fonder ABas of 31 Mar 2025 | 2.12k | 0.01% |
| Skandia Investment Management ABas of 28 Nov 2025 | 709.00 | 0.00% |
| Danske Bank A/S (Investment Management)as of 31 Jan 2026 | 523.00 | 0.00% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Dec 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
